UCF MammoChat: Image Repository
Part of paid clinical trials in Orlando, Florida.
- Sponsor
- University of Central Florida
- Study ID
- NCT07214883
- Status
- Recruiting
Conditions
- Breast Cancer
- Breast Cancer Awareness
- Breast Cancer Detection
- Breast Cancer Diagnosis
- Breast Cancer Female
- Breast Cancer Survivors
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- No Interventions — OTHERNo intervention for participants.
Study Details
This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes. This study also aims to provide mammography images to participants.
Key Dates
- Start date
- Sep 3, 2025
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 20,000 participants (estimated)
Arms
- Arm: Breast Cancer PatientsPatients who have a been diagnosed with breast cancer
- Arm: ControlsNo breast cancer diagnosis
Primary Outcome Measure
AI model training using mammograms [ Time Frame: 1 year ]
Central Contacts
- Amoy Fraser, PhD, CCRP, PMP4072668742
- Britney-Ann Wray, BS, CTBS, CCRP4072668742
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Central Florida | Orlando | Florida | 32827 | Jane C Gibson, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Orlando, FL
By condition
By specialty
By research site
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study)Recruiting · University of California, San Francisco · Birmingham, Alabama
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama